ABSTRACT
INTRODUCTION
Nucleotide polymorphisms at certain HLA loci correlate with susceptibility to a variety of autoimmune diseases, such as type 1 (insulin-dependent) diabetes (recently reviewed in References 9 and 19) . Genetic studies of diabetics and their immediate family members have provided critical information, identifying genetic markers for diabetes (3, 4, 6) , with specific polymorphisms of the HLA-DQB1 locus being the strongest indicators of type 1 diabetes mellitus susceptibility (2, 18, 29) .
Methods for screening the highly polymorphic HLA loci for alleles associated with disease are important for risk evaluation of genetically susceptible individuals. HLA-DQB1 alleles containing a polymorphism encoding the presence of a neutral amino acid residue (e.g., alanine, valine, or serine) at amino acid 57 represent one type 1 diabetes susceptibility marker, while an aspartate at the same position (Asp-57) confers resistance (2, 15, 16, 27, 29) . However, sequence data, including that of the DQ and DRB alleles, result in haplotype information that can be used to better interpret the degrees of association and susceptibility of various genotypes for type 1 diabetes. Moreover, high-resolution typing of the HLA region is required for successful kidney (11, 28) and bone marrow (7, 12, 26) transplantation.
Advances in DNA sequencing technology via automated acquisition and analysis are important additions to the screening and characterization of genetic markers. Pyrosequencing ™ (Pyrosequencing AB, Uppsala, Sweden) methodology represents an improvement to data acquisition, analysis, and allelic identification, including the advantages of real-time data output, resistance to sequencing artifacts associated with analysis by gel electrophoresis, no need for DNA fluorescent labeling, and compatibility with 96-and 384-well microplate formats (22, 25) .
Pyrosequencing was originally designed for expressed sequence tag sequencing in which short (roughly 10-nucleotide) stretches of DNA are analyzed. The pyrosequencing method (22) is a four-enzyme process combining the activities of DNA polymerase, ATP sulfurylase, luciferase, and apyrase. Briefly, the method can be described in four steps: ( i ) hybridization of sequencing primer to an ssDNA template; ( ii ) incorporation of a complementary nucleotide and release of pyrophosphate; ( iii ) use of ATP sulfurylase to convert pyrophosphate and exogenous adenosine 5 ′ phosphosulfate into ATP, followed by conversion into light via the activity of luciferase; and ( iv ) degradation of unincorporated dNTP by means of apyrase. Sequencing continues by reiteration of steps 2-4 using the next dNTP to be tested for incorporation into the nascent nucleotide chain. The data output is represented graphically by a "pyrogram" consisting of a plot of time versus intensity of light produced (23) . Generation of light represents incorporation of a particular nucleotide. In our hands, pyrosequencing has been readily able to read DNA sequences of up to 70 nucleotides. An important advantage of pyrosequencing over other sequencing technologies is that nucleotides are tested individually for incorporation into nascent DNA. The result is that mixed populations of DNA expected from heterozygous individuals are sequenced independently, allowing the resolution of allelic combinations that are impossible to distinguish by conventional sequencing approaches.
Our study was meant to explore the use of pyrosequencing to identify alleles of the various HLA genes in which polymorphic DNA stretches of greater than 250 nucleotides are generally considered. Samples of genomic DNA prepared from human HLA homozygous cell lines developed by the 11th International Histocompatibility Workshop (8) and samples from the Children's Hospital of Pittsburgh (CHP) Histocompatibility Center study of diabetics and their first-degree relatives listed in the Allegheny County Diabetes Registry (6,13) were selected for genotype analysis. Pyrosequencing was initially used to identify alleles frequently detected with the CHP Histocompatibility Center study population, resulting in high-resolution typing of the highly polymorphic exon 2 region of the HLA-DQB1 gene. Pyrosequencing easily completed a 70-nucleotide read length of each sample in a 96-well sample tray within an hour's time, potentially yielding 768 sequence reactions in an 8-h shift or as many as 3072 when performed in a 384-well format, which is sufficient to fully sequence the polymorphic exon 2 region of HLA-DQB1 from roughly 768 individuals. Its accuracy and throughput make pyrosequence-based typing an important addition to the methods available for the identification of known markers in genetic studies and genotyping donors for transplant recipient matching.
MATERIALS AND METHODS

Materials
Genomic DNA samples were obtained from donors studied at the CHP Histocompatiblity Center among the diabetics and their first-degree relatives listed in the Allegheny County Diabetes Registry (6, 13) or from lymphoblastoid cell lines made available on the occasion of the 11th International Histocompatibility Workshop that are each homozygous for one of the 12 different, most common, DQB1 alleles (8) . Oligonucleotides were purchased from Operon Technologies (Alameda, CA, USA) or synthesized on-site using a model 394 DNA/RNA synthesizer (Applied Biosystems, Foster City, CA, USA) ( Table  1 ). Biotinylated oligonucleotides were purified using HPLC. The pyrosequencer was purchased from Pyrosequencing AB. Reagents for pyrosequencing were obtained from Pyrosequencing AB and used as recommended. All other chemicals and reagents were of the highest quality obtainable. Primers DQBamp-A and DQBamp-B were designed by the 11th International Histocompatibility Workshop (8) . Primers SR25, SR22, and SR24 were designed following the recommendations of Pera et al. (17) but with the additional constraint of avoiding formation of self-priming 3 ′ secondary structure during pyrosequencing. Primers SR26, SR27, PSQ3, and SR30 are the minimal primer set required for complete sequencing of DQB1 exon 2. Table 1 . Oligonucleotide Primers Used for PCR and DNA Sequencing 3 min, followed by 32 cycles at 96°C, 55°C, and 72°C incubation for 30 s at each step. PCR cycling was followed by a final 5-min incubation at 72°C. Samples were then stored at -20°C. Pyrosequence reactions were performed using 20-40 µ L amplified DNA from the PCR mixture. Samples were mixed with 4 µ L streptavidincoated beads purchased from Amersham Biosciences (Piscataway, NJ, USA) in Binding Buffer (Pyrosequencing AB) for 10 min with vigorous mixing. Beads were transferred to a filtration apparatus, and the Binding Buffer was removed by vacuum. DNA attached to the streptavidin beads was denatured by incubation for 1 min in 50 µ L Denaturation Buffer (Pyrosequencing AB) and washed twice with 150 µ L Wash Buffer (Pyrosequencing AB). Beads were suspended in 50 µ L Annealing Buffer (Pyrosequencing AB), and 40 µ L were transferred to the 96-well PSQ™ plate (Pyrosequencing AB). The appropriate sequencing primer was added in a volume of 5 µ L using a 3 µ M stock solution. Primer annealing was performed by incubating the samples at 80°C for 2 min. Samples were allowed to cool for 5 min at room temperature (usually 24°C) and sequenced by pyrosequencing. A detailed description of the pyrosequencing reaction conditions has been recently published by Gharizadeh et al. (10) . Pyrosequence data were quantified and background-corrected using Peak Height Determination Software v1.1 (Pyrosequencing AB).
Methods
PCR
Pyrosequence-based typing simulation software (unpublished data) was developed in Perl v5.6.1 provided by ActiveState Tool (Vancouver, BC, Canada) under the General Public License. Simulation software was used to generate the expected pyrosequence-associated peak heights by comparing nucleotide dispensation orders used during pyrosequencing to allelic sequence data. Pyrosequence-based typing simulation software also compared simulated peak height data for each possible heterozygous allelic combination to distinguish unique and ambiguous allelic combinations. Documentation for Perl can be found at http://www.perl. com. The pyrosequence-based typing simulation software is available upon request.
RESULTS
Oligonucleotide-Based Studies
Pyrosequencing has been applied here to the problem of human leukocyte antigen (HLA) typing. Experiments were designed to evaluate the method's suitability for reading nucleotide sequences modeled after HLA-DQB1 alleles *05011 and *0201 (oligonucleotides SR11 and SR14, respectively) ( Table 1) . Oligonucleotide samples were designed so that a hairpin structure, formed at the 3 ′ -end, would allow self-priming for DNA sequencing (24) . Pyrosequencing was performed on the individual oligonucleotides (Figure 1, A and B) . For each sample, the complete 20-nucleotide read length was obtained, consisting of the expected signal intensities for incorporation of up to three identical nucleotides in a row ( Figure 1A , dispensation G4). Sequencing of a solution containing an equal mixture of both oligonucleotides ( Figure 1C ) was performed to simulate the data expected from a heterozygous individual. The resulting pyrogram appeared to reflect correctly the expected signal intensities, as judged from an examination of the single sequence data ( Figure 1, A and B) . For example, in Figure 1C , oligonucleotide SR11 exhibited sequence-specific signal at dispensations G4, C19, and A21, while oligonucleotide SR14 resulted in specific signals at dispensations T1, C3, G12, and G22. The signal associated with the incorporation of the last nucleotide in the nascent chain was lower than expected, probably the result of poor processivity at this position.
Peak signal intensities from the pyro - grams in Figure 1 were quantified and background-corrected. Additional analysis was performed by comparison of the observed signal intensities from the mixture of oligonucleotides SR11 and SR14 ( Figure 1C ) with the calculated signal intensities obtained from sequencing these oligonucleotides individually ( Figure 1, A and B) . As illustrated in Figure 2, 
Pyrosequence-Based Typing of HLA-DQB1 Allele *0301
Genomic DNA containing the HLA-DQB1 gene was prepared by PCR amplification using exon 2-specific primers DQBamp-A and DQBamp-B used in the 11th International Histocompatibility Workshop (8) . DNA obtained from the HLA homozygous cell line BM16 (DQB1*0301) resulted in a single PCR product of the expected molecular weight when analyzed by gel electrophoresis (data not shown). However, the resulting pyrogram indicated the presence of at least two sequences ( Figure 3A) , as would be expected from a heterozygous source. For example, the anticipated sequence obtained from the HLA-DQB1*0301 allele using oligonucleotide primer PSQ1 is initially TTAT -GTGA, while the observed sequence exhibited a strong G signal at dispensation G4. Moreover, the signal intensities at nucleotide dispensations T1, A2, A11, A33, G34, and A35 are of one range, while the other dispensations exhibited much higher intensity, as though a second sequence was present and at a higher molar concentration.
Quantification of peak heights, followed by subtraction of the signal expected from the DQB1*0301 allele, resulted in the unmasking of a DNA sequence associated with a slope of roughly 0.99 and a correlation coefficient of approximately 0.92, when the observed signal intensities were compared to the calculated intensities for the DQB1*0301 sequence and the second sequence ( Figure 3A) . Identification of the DNA sequence was perVol. 33, No. 1 (2002) Figure 2 . Plot of the observed signal intensity versus the calculated signal intensity for the oligonucleotide mixture of SR11 and SR14. Data were quantified from the pyrograms in Figure 1 using Peak Height Determination Software v1.1 and were background-corrected. Observed signal intensity was obtained using the peak height values from Figure 1C , while calculated signal intensity was determined using peak height values from Figure 1 , A and B, assuming an equal molar ratio of the two oligonucleotides. Calculated signal intensity for each peak is defined as 0.5 × [(observed signal intensity for SR11) + (observed signal intensity for SR14)]. Linear regression analysis indicated a correlation coefficient of 0.99 and a slope and intercept of 1.04 and 0.71, respectively.
formed by BLAST analysis (1) against the publicly available human database, resulting in a complete match to a 27-nucleotide region of the HLA pseudogene DQB2 ( Figure 3A) . Moreover, BLAST analysis using the PCR primer sequences resulted in a complete match to regions of the pseudogene such that the expected PCR product would have a base-pair length identical to that obtained from amplification of DQB1 (data not shown). Identification of the combination of sequences DQB1*0301 and DQB2 indicated the usefulness of PSBT in HLA genotyping. However, the 11th International Histocompatibility Workshop primers, while previously considered sufficient for other genotyping technologies, are inappropriate for sequence-based typing methods requiring specific amplification of the DQB1 locus (17) , possibly having contributed to ambiguous genotype analysis of HLA-DQB1.
Reengineered PCR primers SR22, SR24, and SR25 (Table 1) were synthesized following the recommendations of Pera et al. (17) , with the intention of maximizing specific amplification of the DQB1 locus, but modified to avoid formation of self-priming 3 ′ secondary structure that during pyrosequencing can lead to primer extension (24) . PCR amplification of genomic DNA yielded a product of the expected molecular weight when analyzed by gel electrophoresis (data not shown). Pyrosequencing of the amplified DNA obtained from cell line BM16 ( Figure 3B ) resulted in a pyrogram for the expected DQB1*0301 allelic sequence, the result of a roughly 80% reduction in signal associated with the contaminating pseudogene (compare nucleotide dispensation G4 in Figure 3, A and B) . Low-intensity signals at dispensations G4, C19, and G22 may indicate the presence of an additional contaminating PCR product, suggesting that further optimization of the PCR amplification step may result in improved data for pyrosequence-based typing.
Pyrosequence-Based Typing of Genomic DNA from the CHP Study Samples
Pyrosequence-based typing was performed, using DNA extracted from peripheral blood mononuclear cells of diabetic patients and their immediate family members, on allelic combinations frequently observed in the CHP study population (16) . Figure 4 shows data representing a 70-nucleotide length read of exon 2 of the HLA-DQB1 gene for a HLA-DQB1*0302 homozygous individual ( Figure 4A ) and for a HLA-DQB1*0201-02+*0302 heterozygous individual ( Figure 4B ). Pyrograms exhibited the expected peak intensities for the homozygous and heterozygous combination (Figure 4) . Amplified genomic DNA from the homozygous individual ( Figure 4A ) exhibited peak intensities corresponding to the expected sequence for the *0302 allele; variations in signal intensity correlated to the number of nucleotide residues incorporated.
Pyrosequencing exhibited a drop in overall signal during the complete 69-nucleotide dispensation cycle, which is probably the result of loss of apyrase activity (10) . For the heterozygous individual ( Figure 4B ), signal intensities also correlated to the number of nucleotide residues incorporated, although for the combined *0201-02+ *0302 sequence. Moderately intense signal at nucleotide dispensations A29 and A39 ( Figure 4B ) did not correspond to the expected allelic combination, suggesting the presence of a contaminating sequence, indicating that additional optimization of PCR conditions may become necessary to improve the accuracy of pyrosequence-based typing. Complete pyrosequencing of the 270-bp DQB1 gene exon 2 was performed using four sequencing primers (Table 1) and resulted in overlapping pyrosequence information (data not shown).
Pyrosequencing of genomic DNA obtained from individuals containing seven of the most common DQB1 allelic combinations (including the diabetogenic HLA-DQB1*0302 allele in combination with alleles *0201-02, *0301, *0302, or *0501) are summarized in Table 2 . Genotyping was performed on samples from 49 individuals containing alleles accounting for greater than 80% of the total alleles observed in type 1 diabetics and greater than 70% of control Molecular Diagnostic Techniques subjects from the CHP study population (5) . Pyrograms readily distinguished these allelic combinations, leading to their immediate identification as well as being able to resolve ambiguous results obtained from sequence-specific oligonucleotide probe-based typing ( Figure  4 and Table 2 ). An apparent advantage of pyrosequence-based typing, in contrast to hybridization-based methods, is that an oligonucleotide primer initiates the sequencing of a 70-nucleotide region of the allele, while hybridization by oligonucleotide probe identifies only the complementary annealing site. Predictions of the number of oligonucleotide probes required to identify the DQB1 allelic combinations included a high number necessary to distinguish 18 individual codon positions (14) , which is a number of primers similarly required for analysis by mass spectrophotometry-based methods. Pyrosequence-based typing required fewer primers for genotyping of the highly polymorphic HLA locus than hybridization-based methodologies. Simulation of pyrosequencing data was performed for the complete set of DQB1 alleles, using a computer algorithm to generate the predicted pyrograms for each allelic combination. Identification of unique pyrograms was performed by comparing the theoretical results of each possible allelic combination (data not shown). Read lengths were at least 70 nucleotides. Sequencing primer was PSQ3. Axes are nucleotide dispensation event (x-axis) versus observed signal intensity (y-axis).
gave unique pyrograms, a predicted success rate of roughly 99%. Eight allelic pairs yielded identical pyrograms and occurred in four sets: ( i ) *0201-02+*03011/09 or *0203+*0304; ( ii ) *0201-02+*03032 or *0203+*0302; ( iii ) *03011/09+*0302 or *03032+ *0304; and ( iv ) *05012+*0610 or *0502+*0613. Changes to the pyrosequencing protocol (e.g., the order of nucleotide dispensation) may further optimize the ability to distinguish between the remaining allelic combinations (unpublished data). Amplification of DQB1 exons other than exon 2 will be required to distinguish among alleles *0201/*0202, *03011/*0309, and *06011/*06013. A similar analysis, based on methods used in sequencebased typing, has been posted at the IMGT/HLA database (http://www.ebi. ac.uk/imgt/hla/) (20, 21) . In contrast to pyrosequence-based typing, sequencebased typing was predicted to result in 26 ambiguous allelic pairs when the DQB1 gene was examined.
DISCUSSION
Pyrosequencing methodology represents an improvement in automation, including the advantages of real-time data output, absence of sequencing artifacts associated with gel electrophoresis, no need for DNA fluorescent labeling, and compatibility with 96-and 384-well microplate formats. Originally formulated for sequencing short stretches of DNA, pyrosequencing has been evaluated for incorporation into genomic typing protocols with the goal of improving throughput and accuracy of HLA genotyping.
Pyrosequence-based typing of HLA alleles was performed on prevalent allelic combinations observed in diabetics and their first-degree relatives. Pyrograms confirmed the assignment of alleles obtained by sequence-specific oligonucleotide probe-based typing and provided unambiguous additional resolution. Complete sequencing of the highly polymorphic exon 2 of HLA-DQB1 was performed in four reactions, resulting in overlapping sequence information. Different reaction conditions may allow the sequencing of a longer stretch of DNA (10), further reducing the number of overlapping segments needed. Although the polymorphisms at some other HLA loci will result in a more complex analysis, particularly HLA class I loci, the results obtained by sequencing DQB1 alleles can be considered the first step to expand pyrosequencing applications to a complete HLA typing.
Optimization of the pyrosequencebased typing protocol allowed the rapid identification of alleles for the analysis of genetic predisposition to disease and Molecular Diagnostic Techniques for histocompatibility typing. Considering that a single pyrosequencing instrument is capable of performing sequencing of a 96-well tray every hour, up to 1 5 000 sequence reactions can be analyzed within a month. On this basis, pyrosequencing methodology seems to possess all the attributes to enhance the throughput and specificity of HLA typing via the rapid acquisition of DNA sequence information.
